Burkhard Prause
Known title: PRES. & CEO, BRUKER BESTCIK: 0001544726
Associated companies
this person other insiders at BRKRP
Transaction History
| BRKRP | ▲ Buy | Grant | 3,303 | $0 | 8/15/2026 | View on chart |
| BRKRP | ▲ Buy | Grant | 5,298 | $0 | 8/15/2025 | View on chart |
| BRKRP | ▲ Buy | Grant | 2,795 | $0 | 8/9/2024 | View on chart |
| BRKRP | ▲ Buy | Option Exercise | 618 | $38K | 2/22/2024 | View on chart |
| BRKRP | ▼ Sell | Open Market | 15,319 | $1.3M | 2/22/2024 | View on chart |
| BRKRP | ▲ Buy | Option Exercise | 1,846 | $80K | 2/22/2024 | View on chart |
| BRKRP | ▲ Buy | Option Exercise | 1,083 | $37K | 2/22/2024 | View on chart |
| BRKRP | ▲ Buy | Option Exercise | 1,903 | $80K | 2/22/2024 | View on chart |
| BRKRP | ▲ Buy | Grant | 2,371 | $0 | 8/10/2023 | View on chart |
| BRKRP | ▲ Buy | Grant | 2,440 | $0 | 8/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BRKR risk highlighted in recent market analysis
A recent article discusses why Bruker (BRKR) is considered risky, suggesting alternative stocks. This commentary focuses on the parent company's common stock, which may influence sentiment for its preferred shares. The preferred stock has a low dividend yield and trades within a wide 52-week range.
BRKR risk highlighted in recent market analysis. A recent article discusses why Bruker (BRKR) is considered risky, suggesting alternative stocks. This commentary focuses on the parent company's common stock, which may influence sentiment for its preferred shares. The preferred stock has a low dividend yield and trades within a wide 52-week range.